Ischemic Colitis Clinical Trial
Official title:
Assessment of a Composite Prognostic Score to Predict Severe Forms of Ischemic Colitis of Montpellier
| Verified date | December 2020 |
| Source | University Hospital, Montpellier |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Our objective is to determine a prognostic score including CT, clinical and biological criteria predicting the serious (death / surgery) or non-serious (medical treatment) evolution of ischemic colitis and therefore possibly modify the therapeutic management (propose surgical treatment for a severe form based on prognostic score).
| Status | Completed |
| Enrollment | 206 |
| Est. completion date | November 30, 2020 |
| Est. primary completion date | November 1, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion criteria: - Age > or = at 18 years old; - Performing an abdomino-pelvic scan injected within 6 hours of the onset of symptoms; - Ischemic colitis proven by endoscopy or surgical data. Exclusion criteria: - CT scan performed without injection and / or after 6 hours following the onset of symptoms; - Unproven ischemic colitis. |
| Country | Name | City | State |
|---|---|---|---|
| France | Uhmontpellier | Montpellier |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Montpellier |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Complication rate of ischemic colitis | Severe (surgery and/or death) or non severe form of ischemic colitis (medical treatment) : analysis of radiological, biological and clinical data is performed at the time of acute episode of ischemic colitis when the patient is admitted to the hospital or during the stay of the patient previously present in the hospital for another condition | 1 day |